Top

Published in:

01-04-2018 | Correspondence

Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology

Authors: Jannis Kountouras, Stergios A. Polyzos, Panagiotis Katsinelos, Sotiris Anastasiadis, Dimitri Tzivras, Michael Doulberis, Ioannis Venizelos, Elizabeth Vardaka, Constantinos Kountouras, Georgia Deretzi

Published in: Digestive Diseases and Sciences | Issue 4/2018

Excerpt

To the Editor, …

Wijarnpreecha K, Chesdachai S, Thongprayoon C, Jaruvongvanich V, Ungprasert P, Cheungpasitporn W. Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy. Dig Dis Sci. 2017;62:3614–3621.CrossRefPubMed

Arab JP, Martin-Mateos RM, Shah VH. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatol Int. 2017;. https://doi.org/10.1007/s12072-017-9798-x.PubMed

Kountouras J, Zavos C, Deretzi G. Helicobacter pylori might contribute to persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9:624.CrossRefPubMed

Kountouras J, Deretzi G, Zavos C, Katsinelos P. Helicobacter pylori infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension. Ann Gastroenterol. 2014;27:285.PubMedPubMedCentral

Kountouras J, Zavos C, Deretzi G, et al. Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis. Hepatology. 2013;57:1284.CrossRefPubMed

Doulberis M, Kotronis G, Thomann R, et al. Impact of Helicobacter pylori on Alzheimer’s disease: what do we know so far? Helicobacter. 2017;. https://doi.org/10.1111/hel.12454.PubMed

Feng H, Zhou X, Zhang G. Association between cirrhosis and Helicobacter pylori infection: a meta-analysis. Eur J Gastroenterol Hepatol. 2014;26:1309–1319.PubMed

Kountouras J, Deretzi G, Gavalas E, et al. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders. Med Hypotheses. 2014;82:368–373.CrossRefPubMed

Kaltsa G, Bamias G, Siakavellas SI, et al. Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis. Ann Gastroenterol. 2016;29:63–70.PubMedPubMedCentral

10.

Kountouras J, Zavos C, Polyzos SA, Deretzi G. Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration. Ann Gastroenterol. 2016;29:99.PubMedPubMedCentral

Title: Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology
Authors: Jannis Kountouras
Stergios A. Polyzos
Panagiotis Katsinelos
Sotiris Anastasiadis
Dimitri Tzivras
Michael Doulberis
Ioannis Venizelos
Elizabeth Vardaka
Constantinos Kountouras
Georgia Deretzi
Publication date: 01-04-2018
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 4/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-018-4911-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2018

Exposé: Different Faces of a Bleeding Giant Duodenal Ulcer

Gastrointestinal Tract Pathology in a BALB/c Niemann–Pick Disease Type C1 Null Mouse Model

Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis

Clinicopathology and Survival in Patients with Gastroesophageal Reflux After Radical Surgery of Proximal Gastric Cancer

A Tribute to Paul H. Guth, MD (1927–2017)

Adenoma Detection Rate Falls at the End of the Day in a Large Multi-site Sample

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page